Covid-19 tests should be coming to your home ... maybe, we think

Plus, Kazakhstan's president issues shoot-to-kill order against protesters.

Older messages

The Capitol insurrection, one year later

Thursday, January 6, 2022

Plus, Russia sends in troops to quell Kazakhstan unrest. One year later, many Democrats and Republicans have very different views on Trump supporters' attempts to overturn the 2020 elections;

Will small businesses get more Covid cash?

Wednesday, January 5, 2022

Plus, Kazakhstan protests surge in fourth day. Some senators are pushing for more support for small businesses as omicron spreads; Kazakh protests are about much more than the price of oil.

A January voting rights showdown

Tuesday, January 4, 2022

Plus, Israel offers 4th coronavirus vaccine dose Senate Majority Leader Chuck Schumer pushes a vote on voting rights reform; Israel offers a fourth Covid-19 vaccine shot for at-risk residents.

Omicron: New year, new struggle for schools

Monday, January 3, 2022

Plus, the prime minister of Sudan resigns. Real quick: We just launched our first-ever newsletter course, a practical guide to eating less meat. Nearly a quarter of Americans say they are trying to cut

Will you help us close the gap?

Friday, December 31, 2021

Today is the last day ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

You Might Also Like

How to Beat the Market 3:1

Tuesday, April 23, 2024

This advisory has returned a massive 838% since inception compared to the 273% return from the S&P 500 View in browser Fellow Investor, My father Malcolm taught me never to let a good opportunity

I’m as smooth as a seal

Tuesday, April 23, 2024

The best body razor ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

Mehdi Hasan Is the ‘Debate Me’ Bro

Tuesday, April 23, 2024

Columns and commentary on news, politics, business, and technology from the Intelligencer team. Intelligencer the media The 'Debate Me' Bro Mehdi Hasan's aggressive interviewing style

How Android Intelligence built a thriving paid membership

Tuesday, April 23, 2024

When JR Raphael launched his Android Intelligence newsletter in 2018, it was mainly a roundup of news meant to complement his Computerworld column of the same name. But as the newsletter amassed an

This is not your typical email from The Intercept

Tuesday, April 23, 2024

You don't usually hear from me, but my name is Michael Sherrard, and I'm the person at The Intercept in charge of making sure we meet our membership fundraising goals. You don't usually

Wednesday Briefing: Senate votes on Ukraine aid

Tuesday, April 23, 2024

Also, a former tabloid publisher testifies against Donald Trump. View in browser|nytimes.com Continue reading the main story Ad Morning Briefing: Asia Pacific Edition April 24, 2024 Author Headshot By

Coming Up! Civic Engagement & Social Entrepreneurship on May 5, 2024!

Tuesday, April 23, 2024

This extraordinary community event is free and open to the public GeekWire is pleased to present this special sponsored message to our Pacific NW readers. SAAS Summit: Civic Engagement & Social

Surfin MIA

Tuesday, April 23, 2024

Life Beyond Search, Trump's Tab Low ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

Big FTC news today: Noncompetes

Tuesday, April 23, 2024

Vote passes. Real change will take years. ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

After lobbying from Uber and DoorDash, new proposal could overhaul minimum wage law

Tuesday, April 23, 2024

Microsoft's headquarters campuses connected by new pedestrian bridge ADVERTISEMENT GeekWire SPONSOR MESSAGE: Science Firsthand: Learn how Bristol Myers Squibb unlocked the potential of CAR T cell